Prof. FİLİZ AKYÜZ

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.33, no.11, pp.945-954, 2022 (SCI-Expanded)

42. ASSOCIATION OF HLA-DQ POLYMORPHISMS WITH HEPATITIS B VIRUS INFECTION IN TURKISH POPULATION

Çakal B., Arıkan M., Atasoy A., Çavuş B., Poda M., Bulakçı M., et al.

Sabiad , vol.5, no.3, pp.186-192, 2022 (Peer-Reviewed Journal)

43. SINGLE CENTER EXPERIENCE OF WILSON DISEASE

Demir K., Ormeci A. C., Cavus B., Akyuz F., Besisik F., Kaymakoglu S.

HEPATOLOGY , vol.76, 2022 (SCI-Expanded)

44. IL28B rs12979860 and rs8099917 polymorphisms in patients with chronic hepatitis C and non-viral liver disease

ÇAKAL B., ÇAVUŞ B., Atasoy A., ALTUNOK D., PODA M., BULAKÇI M., et al.

ANNALS OF CLINICAL AND ANALYTICAL MEDICINE , no.10, pp.1131-1136, 2022 (ESCI)

45. Tenofovir Disoproxil Fumarate-Related Metabolic Syndrome and Steatohepatitis in a Case of Chronic Hepatitis B

Ozturk N. B., Akyuz M., GÜLLÜOĞLU M., AKYÜZ F.

AMERICAN JOURNAL OF GASTROENTEROLOGY , no.10, 2022 (SCI-Expanded)

46. Localized Lymphoid Hyperplasia of the Colon Mimicking MALT-Lymphoma in a Patient With Ulcerative Colitis

Ozturk N. B., Akyuz M., GÜLLÜOĞLU M., AKYÜZ F.

AMERICAN JOURNAL OF GASTROENTEROLOGY , no.10, 2022 (SCI-Expanded)

47. Prevalence of occult hepatitis B infection in liver biopsy sample of patients with nonviral liver disease

Çakal B., Atasoy A., Çavuş B., Poda M., Bulakçı M., Güllüoğlu M., et al.

FUTURE VIROLOGY , vol.17, no.10, pp.733-742, 2022 (SCI-Expanded) Sustainable Development

48. Cell-free methylation of RASSF1 and CDKN2AIP genes in the diagnosis of hepatocellular carcinoma associated with hepatitis B virus cirrhosis

Telli P., Ozturk N. B., Hakan M. T., Cavus B., Ormeci A. C., Yakut A., et al.

HEPATOLOGY FORUM , vol.3, no.3, pp.77-81, 2022 (ESCI) Sustainable Development

49. Comparison of S gene mutations in patients with occult and chronic hepatitis B virus infection

Cakal B., Cavus B., Atasoy A., Altunok D., Poda M., Bulakcı M., et al.

VIRUS RESEARCH , vol.318, 2022 (SCI-Expanded, Scopus) Sustainable Development

50. What is the effect of subepithelial lesions of the esophagus on esophageal motility?

Oermeci A., Cavus B., Akas R., Istemihan Z., Imanov Z., Senkal V., et al.

European review for medical and pharmacological sciences , vol.26, no.17, pp.6300-6309, 2022 (SCI-Expanded) Sustainable Development

51. What is the clinical impact of occult HBV infections and anti-HBc positivity in patients with chronic hepatitis C?

Cakal B., Cavus B., Atasoy A., Poda M., Bulakci M., Gulluoglu M., et al.

MICROBIOLOGY AND IMMUNOLOGY , vol.66, no.8, pp.386-393, 2022 (SCI-Expanded, Scopus) Sustainable Development

52. Is anterior segment OCT superior to slit-lamp biomicroscopic examination for Kayser Flesicher ring in Wilson's disease?

Ormeci A., Bayraktar S., Isik A. O., Cavus B., Akas R., Istemihan Z., et al.

European review for medical and pharmacological sciences , vol.26, no.14, pp.5178-5185, 2022 (SCI-Expanded)

53. Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

Savarino E., Zingone F., Barberio B., Marasco G., Akyuz F., AKPINAR H., et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL , vol.10, no.6, pp.556-584, 2022 (SCI-Expanded) Sustainable Development

54. Cyclosporine Therapy as a Rescue Treatment in Steroid Refractory Acute Severe Ulcerative Colitis: A Real Life Data From a Tertiary Center

Evirgen S., Iliaz R., Akyuz F., Cavus B., Gokturk S., Ormeci A., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.33, no.6, pp.463-469, 2022 (SCI-Expanded)

55. Investigation of possible associations between tryptophan/kynurenine status and FOXP3 expression in colorectal cancer

Ay E. N., Demirkol S., Hakan M. T., Horozoglu C., Arikan S., Dogan M. B., et al.

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION , vol.82, no.3, pp.185-191, 2022 (SCI-Expanded) Sustainable Development

56. Improvement of Work Productivity and Quality of Life with Anti-Tumor Necrosis Factor Treatment Used in Crohn's Disease in Routine Clinical Practice in Turkey

TÖRÜNER M., BAŞARANOĞLU M., ATUĞ Ö., Senturk O., Akyuz F., Cekic C., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.33, no.5, pp.406-413, 2022 (SCI-Expanded)

57. A New Risk-Scoring System for Colorectal Cancer and Polyp Screening by Turkish Colorectal Cancer and Polyp Study Group

Erdem L., Akbal E., Kocak E., Tucer D., ÜÇBİLEK E., UYANIKOĞLU A., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.33, no.4, pp.286-293, 2022 (SCI-Expanded) Sustainable Development

58. Are Hepatobiliary Manifestations Related to the Site of Involvement in Inflammatory Bowel Disease?

İstemihan Z., Çifcibaşı Örmeci A., Çavuş B., Şenkal İ. V., İmanov Z., Nuriyev K., et al.

Journal of Enterocolitis , vol.1, pp.12-16, 2022 (Peer-Reviewed Journal)

59. Evaluation of safety and efficacy of tenofovir disoproxil in hemodialysis and renal transplant patients monoinfected with hepatitis B virus based on real life data.

Akyüz F., Çavuş B., Nizam N., Göktürk S., Baran B., Yazıcı H., et al.

Clinical and experimental hepatology , vol.8, no.1, pp.7-13, 2022 (Peer-Reviewed Journal) Sustainable Development

60. Is Having Inflammatory Bowel Disease a Risk Factor for Severe Acute Respiratory Syndrome Coronavirus 2?

Çavuş B., Akyüz F., Örmeci Çifçibaşı A., Özgür İ., Erel C., Yakut A., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.33, no.3, pp.196-204, 2022 (SCI-Expanded) Sustainable Development

61. Is there any predictor for relapse after treatment withdrawal in autoimmune hepatitis patients in the real life?

Cavus B., Akyuz F., Iliaz R., Atasoy A., Akyuz U., Demir K., et al.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY , vol.36, 2022 (SCI-Expanded) Sustainable Development

62. Septic arthritis: a presentation of Crohn's disease

Ozpolat H. T., Baran B., Akyuz F.

LANCET GASTROENTEROLOGY & HEPATOLOGY , vol.7, no.2, pp.196, 2022 (SCI-Expanded)

63. EVALUATION OF HELICOBACTER PYLORI FREQUENCY AND GASTRIC ANTRUM PATHOLOGY FINDINGS IN PATIENTS WITH PORTAL HYPERTENSION

Cavus B., Ormeci A., Evirgen S., Iliaz R., Atasoy A., Yegen G., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.85, no.2, pp.211-215, 2022 (ESCI)

64. The effects of IL28B rs12979860 and rs8099917 polymorphism on hepatitis B infection

ÇAKAL B., ÇAVUŞ B., Atasoy A., ALTUNOK D., PODA M., BULAKÇI M., et al.

NORTHERN CLINICS OF ISTANBUL , vol.9, no.5, pp.439-444, 2022 (ESCI, Scopus, TRDizin)

65. A mysterious cause of recurrent acute liver dysfunction for over a decade

Dirim A. B., Kalayci T., Guzel Dirim M., Demir S., Cavus B., Cifcibasi Ormeci A., et al.

GASTROENTEROLOGY REPORT , vol.10, 2022 (SCI-Expanded)

66. Can Interferon Therapy Change the Natural Course of Hepatitis Delta Infection?: a Clinical and Pathological Study

BAKKALOĞLU O. K., Yildirim O., Cavus B., Evirgen S., Gokturk S., Ormeci A., et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , vol.66, no.1, 2022 (SCI-Expanded) Sustainable Development

67. Is belching increasing after bariatric bypass surgery in the long term period?

Akyüz F., Göksoy B., Telli P., Nizam N., Atasoy A., Çavus B., et al.

Acta gastro-enterologica Belgica , vol.84, no.4, pp.601-605, 2021 (SCI-Expanded)

68. Prevalence and Association of Restless Leg Syndrome, Depression and Anxiety in Patients With Inflammatory Bowel Disease

Iliaz R., Ozturk N. B., Kilicarslan A. F., Akas R., Guzey D. Y., Senel E., et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY , vol.116, 2021 (SCI-Expanded)

69. Endoscopic Gastrointestinal Anastomosis Using Lumen-apposing Metal Stent (LAMS) for Benign or Malignant Etiologies A Systematic Review and Meta-Analysis

Hakim S., Khan Z., Shrivastava A., Koroglu E., Patil P., Akyuz F., et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY , vol.55, no.7, 2021 (SCI-Expanded) Sustainable Development

70. Presenting Turkish Inappropriate Medication Use in the Elderly (TIME) Criteria Set in Turkish

BAHAT-ÖZTÜRK G., İLHAN B., ERDOĞAN T., Halil M., SAVAŞ E. S., ÜLGER Z., et al.

EUROPEAN JOURNAL OF GERIATRICS AND GERONTOLOGY , vol.3, no.2, pp.40-100, 2021 (ESCI, Scopus, TRDizin) Sustainable Development

71. ANALYSIS OF GENOTYPE, SUBGENOTYPE AND SEROTYPE OF OCCULT HEPATITIS B VIRUS

Cakal B., Atasoy A., Cavus B., Ormeci A., Poda M., Bulakci M., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.84, no.3, pp.402-410, 2021 (ESCI, TRDizin) Sustainable Development

72. Turkish IBD Organization's Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic

TÖRÜNER M., Kalkan I. H., Akyuz F., Tezel A., ÇELİK A. F.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.32, no.6, pp.488-492, 2021 (SCI-Expanded) Sustainable Development

73. The development of extraintestinal manifestation and related risk factors in Crohn's patients

Kayar Y., Dertli R., Konur S., Agin M., Baran B., Ormeci A., et al.

IRISH JOURNAL OF MEDICAL SCIENCE , vol.190, no.2, pp.597-604, 2021 (SCI-Expanded)

74. What are the predictors for recurrence of Crohn's disease after surgery?

Ozgur İ., Kulle C. B., Buyuk M., Ormeci A., Akyuz F., Balik E., et al.

MEDICINE , vol.100, no.14, 2021 (SCI-Expanded, Scopus)

75. ATA Index: A novel score for predicting fibrosis stage in chronic viral hepatitis.

Tugsal H. Y., Yuksel S., Kabacam G., Evirgen S., Akan K., Akyuz F., et al.

Hepatology forum , vol.2, no.1, pp.12-19, 2021 (ESCI)

76. Indications, effectiveness and safety of percutaneous endoscopic gastrostomy: A single center experience and literature review.

Saka B., ZIRTIL C., Erten S. N., Akpinar T. S., Altinkaynak M., Akyuz F., et al.

Asia Pacific journal of clinical nutrition , vol.30, no.1, pp.42-50, 2021 (SCI-Expanded, Scopus) Sustainable Development

77. IMPLICATION OF SERUM IL-17 LEVELS IN CHRONIC HEPATITIS B PATIENTS

ÇAKAL B., ÇAVUŞ B., Atasoy A., Ormeci A., BULAKÇI M., GÜLLÜOĞLU M., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.84, no.1, pp.68-75, 2021 (ESCI)

78. MHC Class I related chain A (MICA), Human Leukocyte Antigen (HLA)-DRB1, HLA-DQB1 genotypes in Turkish patients with ulcerative colitis

Cinar Ç., Demir K., Temurhan S., Akyuz F., Pinarbasi B., Oguz F. S.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , vol.45, no.5, pp.587-592, 2020 (SCI-Expanded)

79. Assessment of prognostic and diagnostic value of some biomarkers in hepatocellular carcinoma.

Çavuş B., Akyuz F., İliaz R., Akyuz U., Duranyıldız D., Serilmez M., et al.

Experimental oncology , vol.42, no.3, pp.208-214, 2020 (Scopus) Sustainable Development

80. Skin lesions indicate cause of acute gastrointestinal bleeding: neurofibromatosis type 1

Ozpolat H. T., Baran B., Akyuz F.

LANCET , vol.396, no.10255, 2020 (SCI-Expanded)

81. What is the effective clinical use of small bowel capsule endoscopy in real life?

Akyuz F., Cavus B., Akyuz U.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.31, no.9, pp.609-613, 2020 (SCI-Expanded)

82. Turkish inappropriate medication use in the elderly (TIME) criteria to improve prescribing in older adults: TIME-to-STOP/TIME-to-START

Bahat G., Ilhan B., Erdogan T., Halil M., Savas S., Ulger Z., et al.

EUROPEAN GERIATRIC MEDICINE , vol.11, no.3, pp.491-498, 2020 (SCI-Expanded, Scopus) Sustainable Development

83. ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment

Adamina M., Bonovas S., Raine T., Spinelli A., Warusavitarne J., Armuzzi A., et al.

JOURNAL OF CROHNS & COLITIS , vol.14, no.2, pp.155-168, 2020 (SCI-Expanded)

84. Efficacy of adalimumab in mild-to-moderate inflammatory bowel disease: Real-life data from single-centre experience in the long-term period

Akyuz F., Ormeci A., Namazova N., Guzel M., Abbasgoulizadeh A., Tahincioglu L., et al.

JOURNAL OF CROHNS & COLITIS , 2020 (SCI-Expanded)

85. Gastroesophageal Reflux in Asymptomatic Patients with Diabetes: An Impedance Study Diabetes, Obesity and Gastroesophageal Reflux

Gokturk S., Akyuz F., Arici S., Alpaslan B., Ormeci A., Soyer O. M., et al.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.128, no.1, pp.52-58, 2020 (SCI-Expanded, Scopus) Sustainable Development

86. The effect of liver test abnormalities on the prognosis of COVID-19.

Medetalibeyoglu A., Catma Y., Senkal N., Ormeci A., Cavus B., Kose M., et al.

Annals of hepatology , vol.19, no.6, pp.614-621, 2020 (SCI-Expanded, Scopus) Sustainable Development

87. The effects of serum levels, and alterations in the genes of binding protein and receptor of vitamin D on gastric cancer

Durak S., Gheybi A., Demirkol S., Arikan S., Zeybek S. U., Akyuz F., et al.

MOLECULAR BIOLOGY REPORTS , vol.46, no.6, pp.6413-6420, 2019 (SCI-Expanded) Sustainable Development

88. Genome-wide Association Study Identifies Genetic Variants Associated With Early and Sustained Response to (Pegylated) Interferon in Chronic Hepatitis B Patients: The GIANT-B Study

Brouwer W. P., Chan H. L. Y., Lampertico P., Hou J., Tangkijvanich P., Reesink H. W., et al.

CLINICAL INFECTIOUS DISEASES , vol.69, no.11, pp.1969-1979, 2019 (SCI-Expanded) Sustainable Development

89. 2019 Expert opinion on biological treatment use in inflammatory bowel disease management

TÖRÜNER M., AKPINAR H., Akyuz F., Dagli U., Hamzaoglu H. O., Tezel A., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.30, 2019 (SCI-Expanded)

90. Changing epidemiology of chronic hepatitis C: patients are older and at a more advanced stage at the time of diagnosis

Iliaz R., Yuce T., Torun S., Cavus B., Gulluoglu M., Bozaci M., et al.

European journal of gastroenterology & hepatology , vol.31, no.10, pp.1247-1249, 2019 (SCI-Expanded) Sustainable Development

91. Risk factors associated with progression to intestinal complications of Crohn disease

Kayar Y., Baran B., Ormeci A., Akyuz F., Demir K., Besisik F., et al.

CHINESE MEDICAL JOURNAL , vol.132, no.20, pp.2423-2429, 2019 (SCI-Expanded)

92. Alginates: From the ocean to gastroesophageal reflux disease treatment

BOR S., Kalkan I. H., ÇELEBİ A., DİNÇER D., Akyuz F., Dettmar P., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.30, 2019 (SCI-Expanded)

93. Evidence of Prostate-Specific Membrane Antigen Expression in Hepatocellular Carcinoma Using 68Ga-PSMA PET/CT

Kuyumcu S., Has-Simsek D., Iliaz R., Sanli Y., Buyukkaya F., Akyuz F., et al.

CLINICAL NUCLEAR MEDICINE , vol.44, no.9, pp.702-706, 2019 (SCI-Expanded, Scopus)

94. Cryptogenic liver cirrhosis and hepatitis E virus (HEV): Are they related?

Akyuz F., Cavus B., Pinarbasi B., Bozaci M., Baran B., Akyuz U., et al.

Annals of Hepatology , vol.18, no.4, pp.585-589, 2019 (SCI-Expanded) Sustainable Development

95. Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?

Akyuz F., Cavus B., Iliaz R., Soyer O. M., Ormeci A., Evirgen S., et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.31, no.7, pp.777-780, 2019 (SCI-Expanded) Sustainable Development

96. Should we worry about incidental gastrointestinal tract involvement in positron emission tomography/computed tomography as gastroenterologist?

Iliaz R., Cavus B., Yegen G., Alcin G., Gulluoglu M., Karaca C., et al.

Acta gastro-enterologica Belgica , vol.81, no.4, pp.471-475, 2018 (SCI-Expanded)

97. Prediciors of colonic pathologies in active acromegaly: single tertiary center experience

ILIAZ R., DOGANSEN S., TANRIKULU S., YALIN G., CAVUS B., GULLUOGLU M., et al.

WIENER KLINISCHE WOCHENSCHRIFT , vol.130, no.17-18, pp.511-516, 2018 (SCI-Expanded)

98. Does the number of mucosal immune cells differ in irritable bowel syndrome and its subtypes?

İLIAZ R., AKYÜZ F., Yeğen G., ÖRMECI A., GÖKTÜRK S., AKYÜZ Ü., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.29, no.4, pp.384-391, 2018 (SCI-Expanded)

99. Mutations in Core Gene Region of Hepatitis B Virus in Patients with Chronic Hepatitis B.

Ciftci S., Keskin F., Abaci N., Akyuz F., Cakiris A., Badur S., et al.

Clinical laboratory , vol.64, pp.303-310, 2018 (SCI-Expanded) Sustainable Development

100. Serum Glypican-3, Vascular Endothelial Growth Factor, and lnterleukin-6 Levels in Hepatocellular Carcinoma

Serilmez M., Akyuz F., Ormeci Ciftcibasi A., Karabulut S., Kaymakoglu S., Yasasever V., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.33, no.1, pp.18-27, 2018 (ESCI)

101. Current state and clinical outcome in Turkish patients with hepatocellular carcinoma

Ekinci O., Baran B., Ormeci A., Soyer O. M., Gokturk S., Evirgen S., et al.

WORLD JOURNAL OF HEPATOLOGY , vol.10, no.1, pp.51-61, 2018 (ESCI)

102. Predicting mortality in patients with spontaneous bacterial peritonitis using routine inflammatory and biochemical markers

Iliaz R., Ozpolat T., Baran B., Demir K., Kaymakoglu S., Besisik F., et al.

European Journal of Gastroenterology and Hepatology , vol.30, no.7, pp.786-791, 2018 (SCI-Expanded) Sustainable Development

103. Recommendation for treatment of hepatitis C virus infection

KAYMAKOĞLU S., Koksal I., KAYMAKOĞLU S., Tabak F., Akarca U. S., Akbulut A., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.28, 2017 (SCI-Expanded) Sustainable Development

104. How is gastroesophageal reflux disease classified?

Akyuz F., Soyer O. M.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.28, 2017 (SCI-Expanded)

105. Which diseases are risk factors for developing gastroesophageal reflux disease?

Akyuz F., Soyer O. M.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.28, 2017 (SCI-Expanded) Sustainable Development

106. Recurrent Hepatocellular Carcinoma in the Right Adrenal Gland 11 Years After Liver Transplantation for Hepatocellular Carcinoma: a Case Report and Literature Review

Sormaz I. C., Yegen G., Akyuz F., Tunca F., Senyurek Y.

INDIAN JOURNAL OF SURGERY , vol.79, no.5, pp.450-454, 2017 (SCI-Expanded)

107. NON-ALCOHOLIC HEPATIC STEATOSIS AND LIVER FEATURES AMONG PATIENTS WITH CHRONIC HEPATITIS B

Ozturk N. B., Ozkan E. Y., Avci M., Iliaz R., Atasoy A., Akyuz F., et al.

ALCOHOL AND ALCOHOLISM , 2017 (SCI-Expanded)

108. The effect of CTLA-4 and CD28 gene variants and circulating protein levels in patients with gastric cancer

Arikan S., Gumus A., Kucukhuseyin O., Coskun C., Turan S., Cacina C., et al.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , vol.42, no.5, pp.551-558, 2017 (SCI-Expanded) Sustainable Development

109. Anti-TNF treatments in Crohn's disease and improvement in work productivity and quality of life: an observational study from Turkey

Toruner M., Basaranoglu M., Atug O., Sentruk O., Akyuz F., Unsal B., et al.

JOURNAL OF CROHNS & COLITIS , 2017 (SCI-Expanded)

110. Role of biochemistry and cytological analysis of cyst fluid for the differential diagnosis of pancreatic cysts A retrospective cohort study

Soyer O. M., Baran B., Ormeci A., Sahin D., Gokturk S., Evirgen S., et al.

MEDICINE , vol.96, no.1, 2017 (SCI-Expanded)

111. Analysis of hepatitis C virus NS5A region in patients with cirrhosis using an ultra-deep pyrosequencing method

Keskin F., Ciftci S., Akyuz F., Abaci N., Cakiris A., Akyuz U., et al.

Clinical Laboratory , vol.63, no.9, pp.1439-1445, 2017 (SCI-Expanded, Scopus) Sustainable Development

112. EVALUATION OF BLASTOCYSTIS SPP. AMONG INFLAMMATORY BOWEL DISEASE PATIENTS WITH DIFFERENT DIAGNOSTIC METHODS AND SUBTYPE ANALYSES

Buyukbaba Boral O., Celik D. G., Iliaz R., Akgul A., Issever H., Akyuz F.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.80, no.1, pp.38-44, 2017 (ESCI) Sustainable Development

113. Belching in irritable bowel syndrome: An impedance study

Obekli T., Akyuz F., Akyuz U., Arici S., Iliaz R., Gokturk S., et al.

Journal of Neurogastroenterology and Motility , vol.23, no.3, pp.409-414, 2017 (SCI-Expanded)

114. What is the clinical yield of capsule endoscopy in the management of obscure bleeding in emergency service?

Ucuncu M. Z., Bademler S., Ilhan M., Gok A. F. K., Akyuz F., Guloglu R.

ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY , no.1, pp.46-50, 2017 (SCI-Expanded, Scopus, TRDizin)

115. Role of several cytokines and adhesion molecules in the diagnosis and prediction of survival of hepatocellular carcinoma

Iliaz R., Akyuz U., Tekin D., Serilmez M., Evirgen S., Cavus B., et al.

Arab Journal of Gastroenterology , vol.17, no.4, pp.164-167, 2016 (SCI-Expanded, Scopus)

116. Prevalence of pancreatic exocrine insufficiency among patients with type 1 and type 2 diabetes mellitus in Turkey - A cross sectional study-

Kadir-Demir K., Karaca C., Ahishali E., Mastanzade M., Celik S., Gul N., et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY , vol.31, pp.254, 2016 (SCI-Expanded) Sustainable Development

117. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels

Ormeci A., Aydın Y., Sumnu A., Baran B., Soyer O. M., Pinarbasi B., et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , vol.52, pp.68-73, 2016 (SCI-Expanded) Sustainable Development

118. Double benefit of long-acting somatostatin analogs in a patient with coexistence of acromegaly and ulcerative colitis

Yarman S., Yalin G. Y., Dogansen S. C., Canbaz B., Tanrikulu S., Akyuz F.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , no.5, pp.559-562, 2016 (SCI-Expanded) Sustainable Development

119. Retention during capsule endoscopy: Is it a real problem in routine practice?

Ormeci A., Akyuz F., Baran B., Gokturk S., Ormeci T., Pinarbasi B., et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , vol.44, no.4, pp.968-975, 2016 (SCI-Expanded)

120. Primary intestinal lymphangiomatosis of the ileum in an adult-the role of surgical approach

Ilhan M., Oner G., Alibeyoglu A., Yegen G., Gok A. F. K., Akyuz F., et al.

JOURNAL OF SURGICAL CASE REPORTS , no.8, 2016 (ESCI, Scopus)

121. A Cross-sectional Study to Assess the Prevalence of Pancreatic Exocrine Insufficiency Among Diabetes Mellitus Patients in Turkey.

Demir K., Karaca C., AHISHALI E., Mestanzade M., Celik S., Gul N., et al.

Pancreas , vol.45, no.7, 2016 (SCI-Expanded) Sustainable Development

122. Does gastroesophageal reflux increase chronic obstructive pulmonary disease exacerbations?

Iliaz S., Iliaz R., Onur S. T., Arici S., Akyuz U., Karaca C., et al.

Respiratory Medicine , vol.115, pp.20-25, 2016 (SCI-Expanded)

123. Comparison of the efficacy of 12 months and longer courses of interferon therapy for the treatment of chronic delta hepatitis: a retrospective cohort study

Soyer O. M., Baran B., Ormeci A., Gokturk S., Aydin E., Onel D., et al.

POSTGRADUATE MEDICINE , vol.128, no.4, pp.432-438, 2016 (SCI-Expanded) Sustainable Development

124. Can Helicobacter pylori be eradicated with high-dose proton pump inhibitor in extensive metabolizers with the CYP2C19 genotypic polymorphism?

ORMECI A., Emrence Z., BARAN B., SOYER O., GOKTURK S., EVIRGEN S., et al.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.20, no.9, pp.1795-1797, 2016 (SCI-Expanded)

125. Obezite ve Gastrointestinal Hormonlar

AKYUZ U., GÜL N., AKYÜZ F.

Tu¨rkiye Klinikleri Gasroenterohepatology-Special Topics , vol.9, no.2, pp.12-15, 2016 (Non Peer-Reviewed Journal) Sustainable Development

126. What is the impact of capsule endoscopy in the long term period?

Ormeci A., Akyuz F., Baran B., Gokturk S., Ormeci T., Pinarbasi B., et al.

WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY , vol.8, no.7, pp.344-348, 2016 (ESCI)

127. Diagnostic and Therapeutic Capability of Double-Balloon Enteroscopy in Clinical Practice

Akyuz U., Akyuz F.

CLINICAL ENDOSCOPY , vol.49, no.2, pp.157-160, 2016 (ESCI)

128. Cyclosporine therapy is effective in acute severe steroid-refractory ulcerative colitis

Iliaz R., Evirgen S., Akyuz F., Cavus B., Pinarbasi B., Karaca C., et al.

JOURNAL OF CROHNS & COLITIS , 2016 (SCI-Expanded)

129. Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole

Ormeci A., Emrence Z., Baran B., Gokturk S., Soyer O. M., Evirgen S., et al.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.20, no.5, pp.879-885, 2016 (SCI-Expanded)

130. Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection

Ormeci A., Akyuz F., BARAN B., SOYER O., GÖKTÜRK S., ONEL M., et al.

European Review for Medical and Pharmacological Sciences , vol.20, no.5, pp.858-865, 2016 (SCI-Expanded)

131. Genetic Variation rs16937012 near the NCOA2 Gene Predicts Sustained Response to Interferon in Chronic Hepatitis B patients: the GIANT-B study

Brouwer W. P., Kowgier M., Tangkijvanich P., Chan H. L., Hou J., Lampertico P., et al.

HEPATOLOGY , vol.62, no.6, 2015 (SCI-Expanded) Sustainable Development

132. Melatonin may have a role in the pathogenesis of functional dyspepsia in males

Ermis F., Uyanikoglu A., Akyuz F., Yonal O., Keskin F., Ciftci S., et al.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.19, no.23, pp.4675-4678, 2015 (SCI-Expanded)

133. Targeting tachykinin receptors for the treatment of functional gastrointestinal disorders with a focus on irritable bowel syndrome

Corsetti M., Akyuz F., Tack J.

NEUROGASTROENTEROLOGY AND MOTILITY , vol.27, no.10, pp.1354-1370, 2015 (SCI-Expanded) Sustainable Development

134. Tenofovir disoproxil fumarate has a substantial efficacy against multidrug-resistant strains of hepatitis B virus

Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.

LIVER INTERNATIONAL , vol.35, no.10, pp.2265-2274, 2015 (SCI-Expanded) Sustainable Development

135. Favorable Survival Time Provided with Radioembolization in Hepatocellular Carcinoma Patients with and Without Portal Vein Thrombosis

Ozkan Z. G., Poyanli A., Ucar A., Kuyumcu S., Akyuz F., Keskin S., et al.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.30, no.3, pp.132-138, 2015 (SCI-Expanded, Scopus)

136. Gastroesophageal reflux in asymptomatic obese subjects: An esophageal impedance-pH study

Akyuz F., Uyanikoglu A., Ermis F., Arici S., Akyuz U., Baran B., et al.

WORLD JOURNAL OF GASTROENTEROLOGY , vol.21, no.10, pp.3030-3034, 2015 (SCI-Expanded)

137. Isoniazid prophylaxis may not prevent tuberculosis reactivation during anti-TNF treatment

Akyuz F., Iliaz R., Evirgen S., Onder S. Y., Koksalan K., Karaca C., et al.

JOURNAL OF CROHNS & COLITIS , 2015 (SCI-Expanded)

138. Acute severe hepatitis and hemophagocytosis in adult onset Still’s disease

Sahutoglu T., Kara E., Dogan I. O., Gulluoglu M., Akyuz F., Besisik F.

Archives of Iranian Medicine , vol.18, no.10, pp.724-728, 2015 (SCI-Expanded) Sustainable Development

139. In Situ Adenocarcinoma of the Ileum in Crohn’s Disease: A Possible Link with Latent CMV Infection?

KAYMAKOĞLU S., Baran B., Goksel S., Ince U., BAKIR B., Bugra D., et al.

Journal of Gastrointestinal Cancer , vol.45, no.1, pp.252-256, 2014 (Scopus)

140. Treatment of Hepatocellular Cancer Due to Hepatitis Delta with Yttrium-90 Radioembolization in a Patient with Cirrhosis: A Case Report

UYANIKOĞLU A., AKYÜZ F., Ermis F., KAYMAKOĞLU S.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.20, no.3, pp.131-133, 2014 (ESCI) Sustainable Development

141. Small bowel mucosal damage in familial Mediterranean fever: results of capsule endoscopy screening

Demir A., Akyuz F., Gokturk S., Evirgen S., Akyuz U., Ormeci A., et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY , vol.49, no.12, pp.1414-1418, 2014 (SCI-Expanded)

142. Non-alcoholic fatty liver disease: What has changed in the treatment since the beginning?

Baran B., Akyuz F.

WORLD JOURNAL OF GASTROENTEROLOGY , vol.20, no.39, pp.14219-14229, 2014 (SCI-Expanded) Sustainable Development

143. Effects of Polymorphisms in Interferon lambda 3 (Interleukin 28B) on Sustained Virologic Response to Therapy in Patients With Chronic Hepatitis D Virus Infection

Yilmaz E., Baran B., Soyer O. M., Onel M., Onel D., Ormeci A., et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , vol.12, no.10, pp.1753-1758, 2014 (SCI-Expanded) Sustainable Development

144. Esophageal dysmotility: think about in diabetes mellitus patients

Gokturk S., Akyuz U., Akyuz F., Gul N., Iliaz R., Karaca C., et al.

NEUROGASTROENTEROLOGY AND MOTILITY , pp.64, 2014 (SCI-Expanded)

145. Irritable bowel syndrome may overlap the other digestive symptoms

Akyuz F., Obekli T., Akyuz U., Iliaz I., Gokturk S., Evirgen S., et al.

NEUROGASTROENTEROLOGY AND MOTILITY , pp.72, 2014 (SCI-Expanded)

146. Infliximab in inflammatory bowel disease: attention to adverse events

Uyanikoglu A., Ermis F., Akyuz F., Pinarbasi B., Baran B., Aydogan T., et al.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.18, no.16, pp.2337-2342, 2014 (SCI-Expanded)

147. Acute hepatitis B due to immune-escape mutations in a naturally immune patient

Kaymakoglu S., Baran B., Onel D., Badur S., Atamer T., Akyuz F.

ACTA GASTRO-ENTEROLOGICA BELGICA , no.2, pp.262-265, 2014 (SCI-Expanded) Sustainable Development

148. Analysis of potential antiviral resistance mutation profiles within the HBV reverse transcriptase in untreated chronic hepatitis B patients using an ultra-deep pyrosequencing method

Ciftci S., Keskin F., Cakiris A., Akyuz F., Pinarbasi B., Abaci N., et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE , vol.79, no.1, pp.25-30, 2014 (SCI-Expanded, Scopus) Sustainable Development

149. A RECURRENT OBSCURE GASTROINTESTINAL BLEEDING

Iliaz R., ERDEM E., Iliaz S., Yegen G., Akyuz F.

NOBEL MEDICUS , no.2, pp.74-76, 2014 (SCI-Expanded) Sustainable Development

150. Rare pancreas tumor mimicking adenocarcinoma: Extramedullary plasmacytoma

AKYÜZ F., Sahin D., Akyuz U., VATANSEVER S.

WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY , vol.6, no.3, pp.99-100, 2014 (ESCI)

151. Clinical significance of serum hepatocyte growth factor (HGF) levels in hepatocellular carcinoma

Karabulut S., Tas F., Akyuz F., Ormeci A., Serilmez M., Soydinc H. O., et al.

TUMOR BIOLOGY , vol.35, no.3, pp.2327-2333, 2014 (SCI-Expanded, Scopus) Sustainable Development

152. Clinical significance of serum circulating insulin-like growth factor-1 (IGF-1) mRNA in hepatocellular carcinoma

Karabulut S., Duranyildiz D., Tas F., Gezer U., Akyuz F., Serilmez M., et al.

TUMOR BIOLOGY , vol.35, no.3, pp.2729-2739, 2014 (SCI-Expanded, Scopus)

153. Treatment failure may lead to accelerated fibrosis progression in patients with chronic hepatitis C

Baran B., Gulluoglu M., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., et al.

JOURNAL OF VIRAL HEPATITIS , vol.21, no.2, pp.111-120, 2014 (SCI-Expanded) Sustainable Development

154. Efficacy of tenofovir in adefovir-experienced patients compared with treatment-naive patients with chronic hepatitis B

KESKİN O., Ormeci A., Baran B., Kabacam G., Tuzun A., Karatayli E., et al.

ANTIVIRAL THERAPY , vol.19, no.6, pp.543-550, 2014 (SCI-Expanded) Sustainable Development

155. Silent neurological involvement in biopsy-defined coeliac patients

Bilgic B., Aygun D., Arslan A. B., BAYRAM A., Akyuz F., Sencer S., et al.

NEUROLOGICAL SCIENCES , vol.34, no.12, pp.2199-2204, 2013 (SCI-Expanded)

156. Influence of a neurokinin-1 receptor antagonist (aprepitant) on gastric sensorimotor function in healthy volunteers

Ang D., Pauwels A., Akyuz F., Vos R., Tack J.

NEUROGASTROENTEROLOGY AND MOTILITY , vol.25, no.12, 2013 (SCI-Expanded) Sustainable Development

157. Co-infection with hepatitis B does not alter treatment response in chronic hepatitis C

Uyanikoglu A., Akyuz F., Baran B., Simsek B. P., Ermis F., Demir K., et al.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY , vol.37, no.5, pp.485-490, 2013 (SCI-Expanded) Sustainable Development

158. Nodular Lymphoid Hyperplasia of Duodenum Caused by Giardiasis

Baran B., Gulluoglu M., Akyuz F.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , vol.11, no.10, 2013 (SCI-Expanded)

159. Durability of sustained virologic response in chronic hepatitis C

UYANIKOĞLU A., Kaymakoglu S., Danalioglu A., Akyuz F., Ermis F., Pinarbasi B., et al.

Gut and Liver , vol.7, no.4, pp.458-461, 2013 (SCI-Expanded) Sustainable Development

160. Effect of Genotypic Differences in CYP2C19 and on Cure Rates for Helicobacter pylori Infection by Triple Therapy With Different Proton Pump Inhibitors

Demir K., ORMECI A., Emrence Z., Gokturk S., Baran B., SOYER O. M., et al.

GASTROENTEROLOGY , vol.144, no.5, 2013 (SCI-Expanded)

161. Efficacy of Tenofovir in Patients with Lamivudine Failure Is Not Different from That in Nucleoside/Nucleotide Analogue-Naive Patients with Chronic Hepatitis B

Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Bozbey H. U., et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , vol.57, no.4, pp.1790-1796, 2013 (SCI-Expanded) Sustainable Development

162. Association of the MEFV Gene Variations With Inflammatory Bowel Disease in Turkey

Akyuz F., Besisik F., Ustek D., Ekmekci C., Uyar A., Pinarbasi B., et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY , vol.47, no.3, 2013 (SCI-Expanded)

163. Food impaction in older age: Think about an eosinophilic esophagitis

Akyuz U., AKYÜZ F., Ozdil K., Altun H., Agan A. F., Agan A.

WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY , vol.5, no.2, pp.79-80, 2013 (ESCI) Sustainable Development

164. Efficacy of pegylated interferon-alpha treatment for 24 months in chronic delta hepatitis and predictors of response

Karaca C., Soyer O. M., Baran B., Ormeci A., Gokturk S., Aydin E., et al.

ANTIVIRAL THERAPY , vol.18, no.4, pp.561-566, 2013 (SCI-Expanded)

165. Route selection for double balloon enteroscopy in patients with obscure gastrointestinal bleeding: Experience from a single center

Akyuz U., Pata C., Kalayci M., Ozdil K., Altun H., Karip B., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.23, no.6, pp.670-675, 2012 (SCI-Expanded)

166. Measurement of the coronary flow velocity reserve in patients with non-alcoholic fatty liver disease

Pinarbasi B., Demir K., Oflaz H., Ahishali E., Akyuz F., Elitok A., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.23, no.6, pp.720-726, 2012 (SCI-Expanded)

167. Massive ascites as the initial manifestation of mantle cell lymphoma: A challenge for the gastroenterologist

Yonal I., Ciftcibasi A., Gokturk S., Yenerel M. N., Akyuz F., Karaca C., et al.

Case Reports in Gastroenterology , vol.6, no.3, pp.803-809, 2012 (Scopus)

168. Questions About Calculating the Effects of Albumin Therapy for Spontaneous Bacterial Peritonitis

Baran B., Akyuz F., Khishigsuren B.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , vol.10, no.8, pp.950, 2012 (SCI-Expanded)

169. Recurrence of Helicobacter pylori After Eradication in Patients with Peptic Ulcer

Ermis F., Akyuz F., Mungan Z.

SOUTHERN MEDICAL JOURNAL , vol.105, no.6, pp.322-323, 2012 (SCI-Expanded)

170. A novel two bases deletion in the albumin gene causes analbuminaemia in a young Turkish man.

CARIDI G., DAGNINO M., Di D., AKYÜZ F., BOZTAS G., BESISIK F., et al.

Clinica chimica acta; international journal of clinical chemistry , vol.413, no.9-10, pp.950-1, 2012 (SCI-Expanded)

171. Skull metastasis from hepatocellular carcinoma with hepatitis C

Ermis F., Dursun M., Kurt R., Akyuz F.

ANNALS OF SAUDI MEDICINE , vol.32, no.3, pp.321-322, 2012 (SCI-Expanded) Sustainable Development

172. Helicobacter Pylori Negative Extranodal Zone B Cell Lymphoma Presented as a Polypoid Gastric Mass: A Case Report.

Akyuz U., Akyuz F., Ozdil K., Altun H., Gulluoglu M., Yilmazbayhan D.

World journal of oncology , vol.3, no.2, pp.91-92, 2012 (Peer-Reviewed Journal)

173. Current hepatitis delta virus type 1 (HDV1) infections in central and eastern Turkey indicate a wide genetic diversity that is probably linked to different HDV1 origins

Le Gal F., Badur S., Al Hawajri N., Akyuz F., Kaymakoglu S., Brichler S., et al.

ARCHIVES OF VIROLOGY , vol.157, no.4, pp.647-659, 2012 (SCI-Expanded) Sustainable Development

174. Does Cholecystectomy Increase the Esophageal Alkaline Reflux? Evaluation by Impedance-pH Technique

UYANIKOĞLU A., Akyuz F., Ermis F., Arici S., Bas G., ÇAKIRCA M., et al.

JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY , vol.18, no.2, pp.187-193, 2012 (SCI-Expanded)

175. Etiological factors of duodenal and gastric ulcers

Uyanikoglu A., Danalioglu A., Akyuz F., Ermis F., Gulluoglu M., Kapran Y., et al.

Turkish Journal of Gastroenterology , vol.23, no.2, pp.99-103, 2012 (SCI-Expanded)

176. Metastatic gastric tumor mimicking gastrointestinal stromal tumor

Akyuz U., Akyuz F., Ozdil K., Firat P.

ACTA GASTRO-ENTEROLOGICA BELGICA , vol.75, no.1, pp.61-62, 2012 (SCI-Expanded)

177. Second-Line Levofloxacin-Based Triple Therapy's Efficiency for Helicobacter pylori Eradication in Patients With Peptic Ulcer

Ermis F., Akyuz F., Uyanikoglu A., Kurt R., Pinarbasi B., Nazik H., et al.

SOUTHERN MEDICAL JOURNAL , vol.104, no.8, pp.579-583, 2011 (SCI-Expanded)

178. Postprandial platelet-poor plasma 5-hydroxytryptamine concentrations during diarrhea and constipation periods of alternatingtype irritable bowel syndrome patients

Sen F., Pinarbasi B., Issever H., Akyuz F., Mungan Z., Kaymakoglu S.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.22, no.3, pp.270-278, 2011 (SCI-Expanded) Sustainable Development

179. Anticoagulant therapy and Budd-Chiari syndrome: Is it successful?

Akyuz F., Cakaloglu Y., Pinarbasi B., Demir K., Akyuz U., Ozdil S., et al.

Hepato-Gastroenterology , vol.58, pp.900-903, 2011 (SCI-Expanded)

180. Effect of proton pump inhibitor (PPI) treatment in obstructive sleep apnea syndrome: An esophageal impedance-pHmetry study

Ermis F., Akyuz F., Arici S., Uyanikoglu A., Yakar F., Pinarbasi B., et al.

Hepato-Gastroenterology , vol.58, pp.1566-1573, 2011 (SCI-Expanded)

181. A rare complication of interferon treatment: optic neuropathy

Gokturk S., Atay K., ÇİFCİBAŞI ÖRMECİ A., Baran B., Soyer O. M., AKYÜZ F., et al.

ANNALS OF GASTROENTEROLOGY , vol.24, no.4, pp.335, 2011 (ESCI)

182. Is portal hypertensive enteropathy an important additional cause of blood loss in portal hypertensive patients?

Akyuz F., Pinarbasi B., Ermis F., Uyanikoglu A., Demir K., Ozdil S., et al.

Scandinavian Journal of Gastroenterology , vol.45, no.12, pp.1497-1502, 2010 (SCI-Expanded)

183. Decreased prohepcidin levels in patients with HBV-related liver disease: relation with ferritin levels.

Yonal O., Akyuz F., Demir K., Ciftci S., Keskin F., Pinarbasi B., et al.

Digestive diseases and sciences , vol.55, no.12, pp.3548-51, 2010 (SCI-Expanded) Sustainable Development

184. Comments on Histologic Predictors of Fibrosis Progression in Posttransplant Hepatitis C Recurrence

Baran B., Karaca C., Akyuz F.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , vol.8, no.8, pp.735, 2010 (SCI-Expanded) Sustainable Development

185. Electron microscopic findings in non-alcoholic fatty liver disease: Is there a difference between hepatosteatosis and steatohepatitis?

Ahishali E., Demir K., Ahishali B., Akyuz F., Pinarbasi B., Poturoglu S., et al.

Journal of Gastroenterology and Hepatology (Australia) , vol.25, no.3, pp.619-626, 2010 (SCI-Expanded)

186. The quality of life in hemodialysis patients with chronic hepatitis C virus infection

Akyuz F., Besisik F., Pinarbasi B., Demir K., Kaymakoglu S., Cakaloglu Y., et al.

Turkish Journal of Gastroenterology , vol.20, no.4, pp.243-246, 2009 (SCI-Expanded) Sustainable Development

187. Utility of esophageal manometry and pH-metry in gastroesophageal reflux disease before surgery

Akyuz F., Arici S., Ermis F., Mungan Z.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.20, no.4, pp.261-265, 2009 (SCI-Expanded)

188. Influence of ghrelin on the gastric accommodation reflex and on meal-induced satiety in man

Ang D., Nicolai H., Vos R., Mimidis K., Akyuz F., Kindt S., et al.

NEUROGASTROENTEROLOGY AND MOTILITY , vol.21, no.5, pp.535-542, 2009 (SCI-Expanded) Sustainable Development

189. Diagnostic Capability of Capsule Endoscopy in Small Bowel Diseases

AKYÜZ F., Mungan Z.

GASTROENTEROLOGY RESEARCH , vol.2, no.2, pp.81-85, 2009 (ESCI)

190. Prevalence and virological features of occult hepatitis B virus infection in female sex workers who work uncontrolled in Turkey.

Pinarbasi B., Onel D., Cosan F., Akyuz F., Dirlik N., Cakaloglu Y., et al.

Liver international : official journal of the International Association for the Study of the Liver , vol.29, no.2, pp.227-30, 2009 (SCI-Expanded) Sustainable Development

191. Are acquired hepatocerebral degeneration and hepatic myelopathy reversible?

Pinarbasi B., Kalymakoglu S., Matur Z., Akyuz F., Demir K., Besisik F., et al.

Journal of clinical gastroenterology , vol.43, no.2, pp.176-81, 2009 (SCI-Expanded)

192. A new agent for tumour necrosis factor-alpha inhibition: In vitro effects of dipyridamole in Crohn's disease

Poturoglu S., Kaymakoglu S., Polat N. G., Ibrisim D., Ahishali E., Akyuz F., et al.

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION , vol.69, no.6, pp.696-702, 2009 (SCI-Expanded)

193. Congenital Portal Vein Aneurysm Associated with Peliosis Hepatis and Intestinal Lymphangiectasia

Mungan Z., Pinarbasi B., Bakir B., Gulluoglu M., Baran B., Akyuz F., et al.

GASTROENTEROLOGY RESEARCH AND PRACTICE , 2009 (SCI-Expanded) Sustainable Development

194. Pyoderma Gangrenosum Treated with Infliximab in Inactive Ulcerative Colitis

Ermis F., Ozdil S., Akyuez F., Pinarbasi B., Mungan Z.

INFLAMMATORY BOWEL DISEASES , vol.14, no.11, pp.1611-1613, 2008 (SCI-Expanded)

195. Intestinal metaplasia in portal hypertensive gastropathy: A frequent pathology

Ibrisim D., Cevikbas U., Akyuz F., Poturoglu S., Ahishali E., Gulluoglu M., et al.

European Journal of Gastroenterology and Hepatology , vol.20, no.9, pp.874-880, 2008 (SCI-Expanded)

196. Response to hepatitis B vaccination in patients with celiac disease

Ahishali E., Boztas G., Akyuz F., Ibrisim D., Poturoglu S., Pinarbasi B., et al.

DIGESTIVE DISEASES AND SCIENCES , vol.53, no.8, pp.2156-2159, 2008 (SCI-Expanded) Sustainable Development

197. Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey

Cakaloglu Y., Akyuez F., Bozaci M., Ibrisim D., Pinarbasi B., Demir K., et al.

Turkish Journal of Gastroenterology , vol.19, no.2, pp.104-108, 2008 (SCI-Expanded) Sustainable Development

198. Rapidly progressive HCV cirrhosis in a hypogammaglobulinemic patient

Ermis F., Akyuez F., Demir K., Besisik F., Boztas G., Mungan Z.

Internal Medicine , vol.47, no.5, pp.415-417, 2008 (SCI-Expanded) Sustainable Development

199. Wireless endoscopy capsule remaining safely for a long time

Mungan Z., Pinarbasi B., Akyuz F., Bektas H., Akyuz A.

DIGESTIVE DISEASES AND SCIENCES , vol.53, no.5, pp.1422-1423, 2008 (SCI-Expanded)

200. What is the cause of obscure bleeding in portal hypertensive patients?

AKYÜZ F., Pinarbasi B., Ernis F., Uyanikoglu A., Mungan Z. A.

GASTROENTEROLOGY , vol.134, no.4, 2008 (SCI-Expanded)

201. Peptic ulcer disease: What did change in Turkey?

Yazici A., AKYÜZ F., İŞSEVER H., Pinarbasi B., DEMİR K., Ozdil S., et al.

GASTROENTEROLOGY , vol.134, no.4, 2008 (SCI-Expanded)

202. MEFV gene mutations and inflammatory bowel disease: Is there any effect?

AKYÜZ F., Besisik F., Pinarbasi B., DEMİR K., KAYMAKOĞLU S., Ozdil S., et al.

GASTROENTEROLOGY , vol.134, no.4, 2008 (SCI-Expanded)

203. Involvement of Nk1 mediated mechanisms in the control of gastric sensorimotor function in man

Ang D. C., Vos R., Geeraerts B., AKYÜZ F., Janssens J., Tack J. F.

GASTROENTEROLOGY , vol.134, no.4, 2008 (SCI-Expanded)

204. A rare cause of hemosuccus pancreaticus: Primary splenic artery aneurysm ruptured into pancreatic serous cystadenoma

Pinarbasi B., Poturoglu S., Yanar H., Gueven K., Akyuez F., Dizdaroglu F., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.19, no.1, pp.57-63, 2008 (SCI-Expanded)

205. HFE gene mutation, chronic liver disease, and iron overload in Turkey

YOENAL O., Hatirnaz O., AKYUEZ F., Oezbek U., Demir K., Kaymakoglu S., et al.

DIGESTIVE DISEASES AND SCIENCES , vol.52, no.11, pp.3298-3302, 2007 (SCI-Expanded)

206. A case of Aeromonas hydrophila enteritis in the course of ulcerative colitis

Ahishali E., Pinarbasi B., Akyuz F., Ibrisim D., Kaymakoglu S., Mungan Z.

EUROPEAN JOURNAL OF INTERNAL MEDICINE , vol.18, no.5, pp.430-431, 2007 (SCI-Expanded) Sustainable Development

207. The effects of rosiglitazone, metformin, and diet with exercise in nonalcoholic fatty liver disease

Akyuez F., Demir K., Oezdil S., Aksoy N., Poturoglu S., Ibrisim D., et al.

Digestive Diseases and Sciences , vol.52, no.9, pp.2359-2367, 2007 (SCI-Expanded)

208. The role of thrombopoietin and spleen volume in thrombocytopenia of patients with noncirrhotic and cirrhotic portal hypertension

Akyuez F., Yekeler E., Kaymakoglu S., Horasanli S., Ibrisim D., Demir K., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.18, no.2, pp.95-99, 2007 (SCI-Expanded)

209. What is the reason of elevated alanine aminotransferase level in HBeAg negative patients with low viremia: NAFLD or chronic hepatitis?

Demir K., Akyuz F., Ozdil S., Aksoy N., Kaymakoglu S., Poturoglu S., et al.

Annals of Hepatology , vol.6, no.2, pp.92-96, 2007 (Scopus) Sustainable Development

210. Long-term results of interferon alpha monotherapy in patients with HBeAg-negative chronic hepatitis B

Kaymakoglu S., Danalioglu A., Demir K., Karaca C., Akyuz F., Onel D., et al.

Digestive Diseases and Sciences , vol.52, no.3, pp.727-731, 2007 (SCI-Expanded) Sustainable Development

211. Definition of C282Y mutation in a hereditary hemochromatosis family from Turkey

Yoenal O., Hatirnaz O., Akyuez F., KOROGLU G., Ozbeik U., Cefle K., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.18, no.1, pp.53-57, 2007 (SCI-Expanded)

212. Lamivudine monotherapy and lamivudine plus interferon alpha combination therapy in HBeAg negative chronic hepatitis B not responding to previous interferon alpha monotherapy

Akyuz F., Kaymakoglu S., Demir K., Aksoy N., Karaca C., Danalioglu A., et al.

Acta Gastro-Enterologica Belgica , vol.70, no.1, pp.20-24, 2007 (SCI-Expanded) Sustainable Development

213. Hydatid cysts: Three different stages on the same image

Ermis F., Dursun M., Akyuz F., Bakir B., Guven K.

INTERNAL MEDICINE , vol.46, no.19, pp.1673, 2007 (SCI-Expanded)

214. Tumor mimicking hepatic echinococcus alveolaris with portal vein thrombosis

Ermis F., Akyuz F., Ekmekci A., Dursun M., Gulluoglu M., Demir K.

INTERNAL MEDICINE , vol.46, no.19, pp.1675-1676, 2007 (SCI-Expanded)

215. Effects of pyridoxine-HCL therapy on serum aminotransferase levels in haemodialysis patients

Demir K., Akyuez F., Aysuna N.

NEPHROLOGY , vol.11, no.5, pp.480, 2006 (SCI-Expanded)

216. An asymptomatic huge hepatocellular carcinoma with intra-atrial tumor thrombus in a patient with chronic hepatitis B viral infection.

Demir K., Akyüz F., Poyanli A., Okten A.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.17, no.3, pp.203-5, 2006 (Scopus)

217. Treatment of hepatic hydrothorax with terlipressin in a cirrhotic patient

Ibrisim D., Cakaloglu Y., Akyuz F., Karadag A., Ozdil S., Besisik F., et al.

Scandinavian Journal of Gastroenterology , vol.41, no.7, pp.862-865, 2006 (SCI-Expanded) Sustainable Development

218. Neutrocytic ascites in noncirrhotic portal hypertension.

Akyüz F., Ibrişim D., Tufan F., Beşişik F., Ökten A.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.17, no.2, pp.155-6, 2006 (Scopus)

219. Evaluation of malignancy risk and endoscopic follow up in achalasia: case report.

Akyüz F., Ibrişim D., Balik E., Yonal O., Kaymakoğlu S., Buğra D., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.17, no.1, pp.46-9, 2006 (Scopus)

220. Postoperative hypofractionated radiotherapy in glioblastoma multiforme

Arslan M., KARADENİZ A. N., Aksu G., Güveli M., Fayda M., DOĞAN A., et al.

Journal of B.U.ON. , vol.11, no.1, pp.39-42, 2006 (SCI-Expanded)

221. Intrahepatic and peripheral T-cell responses in genotype 1b hepatitis C virus-infected patients with persistently normal and elevated aminotransferase levels

Akyuz F., Polat N., Kaymakoglu S., Aksoy N., Demir K., Besisik F., et al.

World Journal of Gastroenterology , vol.11, no.45, pp.7188-7191, 2005 (SCI-Expanded) Sustainable Development

222. Rare complication of interferon alpha therapy : retinal vein thrombosis

Akyuz F., Akyuz U., Kocaman O., Kaymakoglu S.

ACTA GASTRO-ENTEROLOGICA BELGICA , vol.68, no.3, pp.394-395, 2005 (SCI-Expanded)

223. Pneumatic balloon dilatation in primary achalasia: The long-term follow-up results

Boztas G., Mungan Z., Ozdil S., Akyuz F., Karaca C., Kaymakoglu K., et al.

HEPATO-GASTROENTEROLOGY , vol.52, no.62, pp.475-480, 2005 (SCI-Expanded)

224. Peritoneal amyloidosis caused by Familial Mediterranean Fever

Poturoglu S., Mungan Z., Boztas G., Kaymakoglu S., Ozdil S., Akyuz F., et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY , vol.20, no.2, pp.325-326, 2005 (SCI-Expanded)

225. Ribavirin treatment in patients with chronic hepatitis C infection who had renal transplantation

Karaca C., Besisik F., Akyuz F., Dincer D., Sever M., Okten A.

DIGESTIVE SURGERY , vol.22, pp.113, 2005 (SCI-Expanded) Sustainable Development

226. Is there any medical therapeutic option in hepatopulmonary syndrome? A case report

AKYÜZ F., KAYMAKOĞLU S., DEMİR K., Aksoy N., Adalet I., Ökten A.

European Journal of Internal Medicine , vol.16, no.2, pp.126-128, 2005 (Scopus)

227. What is the best indicator for evaluating treatment response in nonalcoholic fatty liver disease: Histology or aminotransferase levels?

Akyuz F., Demir K., Cevikbas U., Okten A.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY , vol.20, no.1, pp.167-168, 2005 (SCI-Expanded)

228. Factor V Leiden is a risk factor for myocardial infarction in young Turkish men

HOBIKOGLU G., AKYUZ U., AKYUZ F., OZER O., GUNEY D. B., NARIN A., et al.

ACTA CARDIOLOGICA , vol.59, no.6, pp.594-597, 2004 (SCI-Expanded)

229. Ulcerative colitis: Analyses of 116 cases (do extraintestinal manifestations effect the time to catch remission?)

Ozdil S., Akyuz F., Pinarbasi B., Demir K., Karaca C., Boztas G., et al.

HEPATO-GASTROENTEROLOGY , vol.51, no.57, pp.768-770, 2004 (SCI-Expanded)

230. Liver abscess as a rare complication of Crohn's disease: a case report.

Karaca C., Pinarbaşi B., Danalioğlu A., Akyüz F., Kaymakoğlu S., Ozdil S., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.15, no.1, pp.45-8, 2004 (Scopus)

231. Crohn's disease; analysis of 105 patients.

Ozdil S., Demir K., Boztas G., Danalioglu A., Karaca C., Akyüz F., et al.

Hepato-gastroenterology , 2003 (SCI-Expanded)

232. Terlipressin and albumin combination treatment in hepatorenal syndrome.

Danalioglu A., Cakaloglu Y., Karaca C., Aksoy N., Akyuz F., Ozdil S., et al.

Hepato-gastroenterology , 2003 (SCI-Expanded)

233. Familial visceral myopathy with pseudo-obstruction, megaduodenum, Barrett's esophagus, and cardiac abnormalities

MUNGAN Z., AKYUZ F., Bugra Z., YONAL O., OZTURK S., ACAR A., et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY , vol.98, no.11, pp.2556-2560, 2003 (SCI-Expanded)

234. Allelle and haplotype frequencies of Y-short tandem repeat loci in Turkey

Ascioglu F., AKYÜZ F., Cetinkaya U., Canli M.

CROATIAN MEDICAL JOURNAL , vol.44, no.3, pp.310-314, 2003 (SCI-Expanded)

235. Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection

Besisik F., Karaca Q., Akyuz F., Horosanli S., Onel D., Badur S., et al.

JOURNAL OF HEPATOLOGY , vol.38, no.4, pp.506-510, 2003 (SCI-Expanded) Sustainable Development

236. Helicobacter pylori eradication lowers esophageal sphincter pressures in functional dyspepsia patients

Besisik F., Surucu F., Mungan Z., Dincer D., Kapran Y., Kaymakoglu S., et al.

HEPATO-GASTROENTEROLOGY , no.42, pp.1772-1775, 2001 (SCI-Expanded) Sustainable Development

237. Helicobacter pylori eradication lowers esophageal sphincter pressures in non-ulcer dispepsia patients.

Besisik F., Surucu F., Dincer D., Kaplan Y., Arici S., Menda Y., et al.

GASTROENTEROLOGY , no.4, 2000 (SCI-Expanded)

238. Anemia and thrombocytopenia due to parvovirus B-19 infection in a pregnant woman

Timuragaoglu A., Surucu F., Nalcaci M., Dincol G., Pekcelen Y.

JOURNAL OF MEDICINE , no.3-4, pp.245-249, 1997 (SCI-Expanded) Sustainable Development

Papers Presented at Peer-Reviewed Scientific Conferences 105

1. A Possible Correlations between OX40 rs17568 A/G Gene Variant and sOX40 serum levels in Gastric Cancer patients

Mohammed Al Khafaji H. M., Elselmo A., Kaleler İ., Sönmez D., Hakan M. T., Horozoğlu C., et al.

10th International Congress of Molecular Medicine, İzmir, Turkey, 23 - 27 September 2024, pp.95, (Summary Text)

2. First Preliminary Report: Potential Implications of IDO1 Expression on Soluble Tryptophan and Tryptophan Catabolites in Gastric Tumors and Tumor Microenvironment

Horozoglu C., Hakan M. T., Sener S., Sonmez Zor D., Aktas F., Küçükhüseyin Ö., et al.

10th International Congress of Molecular Medicine, İzmir, Turkey, 23 - 27 September 2024, pp.78, (Summary Text)

3. The relationship between spleen stiffness and portal hypertension liver transplant patients

Nurıyev K., İstemihan Z., Telli P., Qurbanov A., Yağlı M. A., Dağcı G., et al.

EASL Congress 2024, Milan, Italy, 5 - 08 June 2024, pp.377-378, (Summary Text)

4. Steatotic liver disease in diabetic patients: more serious diabetes mellitus, more serious liver disease

İstemihan Z., Bektaş F., Bardak A. E., Kızıltaş C., Kemeç G., Nurıyev K., et al.

EASL Congress 2024, Milan, Italy, 5 - 08 June 2024, pp.551, (Summary Text)

5. 10-year results under tenofovir disoproxil fumarate and entecavir in chronic hepatitis B; HBV clearance rare, disease outcomes good

İstemihan Z., Kemeç G., Cebeci T., Çetin O., Genç Uluçeçen S., Rüstemzade A., et al.

EASL Congress 2024, Milan, Italy, 5 - 08 June 2024, pp.803, (Summary Text)

6. Clinical characteristics of patients with hereditary hemorrhagic telangiectasia: Real-life data, single-center experience

İstemihan Z., Bardak A. E., Nurıyev K., Rüstemzade A., Genç Uluçeçen S., Çavuş B., et al.

ESGE Days 2024, Berlin, Germany, 25 - 27 April 2024, pp.297, (Summary Text)

7. Otoimmün Tanılı Hastalarda Viral Serolojik Profilin Değerlendirilmesi

Küçükkaya S., Çaklovica Küçükkaya İ., Çavuş B., Safran N., Önel M., Kırkoyun Uysal H., et al.

7. Ulusak Klinik Mikrobiyoloji Kongresi (KLİMUD), Muğla, Turkey, 1 - 05 November 2023, pp.635, (Summary Text)

8. Tofacitinib in Ulcerative Colitis: The Relationship Between OCTAVE Induction Week 8 Symptomatic Remission and OCTAVE Sustain Week 52 Remission

Desreumaux P., AKYÜZ F., Ha C., Bouzidi A., Tamzali A., Gardiner S., et al.

Annual Scientific Meeting of the American-College-of-Gastroenterology (ACG), Vancouver, Canada, 20 - 25 October 2023 Sustainable Development

9. HYPERLIPIDEMIA, ATHEROSCLEROSIS AND HEPATOSTEATOSIS IN PRIMARY BILIARY CHOLANGITIS: WHAT IS THE RISK?

ÇOŞKUN A., Ormeci A. C., ÇAVUŞ B., ŞENKAL İ. V., KARAPINAR E., POYANLI A., et al.

Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America, 10 - 14 November 2023, (Summary Text)

10. Tenofovir resistance-associated mutations at patients with chronic hepatitis B

Çakal B., Çavuş B., Bulakçı M., Güllüoğlu M., Akyüz F.

ESCV 2023 - 25th Annual Meeting of the European Society for Clinical Virology., Milan, Italy, 30 August - 02 September 2023, pp.141-142, (Full Text) Sustainable Development

11. ARE THERE NEW PRACTICAL MARKERS TO PREDICT MALIGNANCY IN PANCREATIC CYST FLUIDS?

Anıl K. U., Çavuş B., Çifcibaşı Örmeci A., İmanov Z., Şenkal İ. V., Nurıyev K., et al.

Digestive Disease Week 2023, Washington, United States Of America, 6 - 09 May 2023, pp.774, (Summary Text)

12. WHAT ARE THE PREDICTORS OF SPLEEN STIFFNESS MEASUREMENT FAILURE BY TRANSIENT ELASTOGRAPHY?

Agargun B. F., Senkal V. I., Rustamzade A., Nuriyev K., Istemihan Z., Imanov Z., et al.

Digestive Disease Week (DDW), Illinois, United States Of America, 6 - 09 May 2023, (Summary Text)

13. Real-world data of tenofovir alafenamide in treatment-naive and experienced patients with Chronic Hepatitis B: more efficacy, less side effects

Bektaş E., Yılmaz A., Kıkılı C. İ., Nurıyev K., İstemihan Z., Şenkal İ. V., et al.

39. Ulusal Gastroenteroloji Haftası ve 10. Gastroenteroloji Cerrahisi Kongresi, Antalya, Turkey, 22 - 27 November 2022, pp.1159-1162, (Summary Text)

14. A CASE OF EXTRAPULMONARY SARCOIDOSIS WITH HYPERLIPIDAEMIA DUE TO GRANULOMATOUS HEPATITIS AND INTRAHEPATIC CHOLESTASIS

Bektaş E., Yılmaz A., Bilgin E., Mutlu Ü., Çavuş B., Çifcibaşı Örmeci A., et al.

24. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 19 - 23 October 2022, pp.136-137, (Full Text)

15. REAL-WORLD DATA OF TENOFOVIR ALAFENAMIDE IN TREATMENT-NAIVE AND EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS B: MORE EFFICACY, LESS SIDE EFFECTS

Bektaş E., Yılmaz A., Kıkılı C. İ., Nurıyev K., İstemihan Z., Şenkal İ. V., et al.

AASLD Liver Meeting , District Of Columbia, United States Of America, 4 - 08 November 2022, vol.76, pp.299, (Summary Text)

16. Dekompanse karaciğer sirozunda ince barsak tutulumlu diffüz büyük b hücreli lenfoma olgusu

Teberik Kama E., İstemihan Z., Çifcibaşı Örmeci A., Akyüz F., Kaymakoğlu S.

24. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 19 - 23 October 2022, pp.140, (Summary Text)

17. İshal ve kilo kaybının nadir bir nedeni:Amiloidoz

Çiftçi A. C., Konyaoğlu H., Şenkal İ. V., Çavuş B., Çifcibaşı Örmeci A., Akyüz F., et al.

21. Çapa Gastroenteroloji Günleri, İstanbul, Turkey, 31 March - 02 April 2022, pp.70, (Full Text)

18. Girişimsel Gastroenterolojik İşlemlerde Hastaların Doktor Tercihinde Cinsiyet Önemli mi?

Kara İnci A., Zaralı S., Akyüz M., İmanov Z., Şenkal İ. V., İstemihan Z., et al.

38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Turkey, 16 - 21 November 2021, pp.204, (Full Text)

19. Ön Segment Optik Koherans Tomografi (OCT), Wilson hastalığı tanısında Kayser Fleischer Halkası varlığını değerlendirmeki yeri - Ehil oftalmolog gerekliliğine son verecek mi?

Çifcibaşı Örmeci A., Bayraktar Ş., Işık A. O., İstemihan Z., Sarıdal M. K., Akas R., et al.

38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Turkey, 16 - 21 November 2021, pp.218, (Summary Text)

20. Budd-Chiari Sendromu’nda Hepatoselüler Kanser ve Mortalitenin Değerlendirilmesi

İstemihan Z., Nurıyev K., Şenkal İ. V., İmanov Z., Sarıdal M. K., Akas R., et al.

38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Turkey, 16 - 21 November 2021, pp.219, (Summary Text) Sustainable Development

21. THE MORPHOMETRIC ASSESSMENT OF HEPATIC ARTERY AND BILE DUCT ON LIVER NEEDLE BIOPSY IN PRIMARY SCLEROSING CHOLANGITIS

Ozturk N. B., Schiano T. D., Fusari E., Fiel D., Akyuz F., Fiel M. I.

Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), ELECTR NETWORK, 13 - 16 November 2020, vol.72, (Summary Text)

22. TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B: WHAT ARE THE TRIGGERS OF DRUG-RELATED ADVERSE EFFECTS?

Kapar C., Cavus B., Atasoy A., Suleymanova V., Isik A., Karahan L., et al.

Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), ELECTR NETWORK, 13 - 16 November 2020, vol.72, (Summary Text) Sustainable Development

23. Bariyatrik by-pass cerrahisi sonrası uzun dönemde geğirti artıyor mu?

AKYÜZ F., TELLİ P., nizam n., GÖKSOY B., ATASOY A., ÇAVUŞ B., et al.

7. Gastroenteroloji Cerrahisi Kongresi, Antalya, Turkey, 29 November - 01 December 2019, pp.99, (Summary Text)

24. Diyabet ve pankreas enzim yetersizliği ilişkisi

BALAMİR M., Avcı B., Coşan E., TANYOLAÇ S., HACİŞAHİNOĞULLARI H., SARIBEYLİLER G., et al.

36. Ulusal Gastroenteroloji Mezuniyet Sonrası Eğitim Toplantısı ve 7. Gastroenteroloji Cerrahisi Kongresi, Antalya, Turkey, 29 November 2019, (Full Text)

25. Mide Kanserinde Kullanılabilecek IDO Metabolik Yolağını Hedefleyen Etkin Bir Kemoimmunonanopartikul Kombinasyonu Etkisinin Araştırılması

YAYLIM İ., Bilici K., Yağcı H. F., Genel M., SÖNMEZ D., HAKAN M. T., et al.

Onkolojide İz Bırakanlar Kongresi, Antalya, Turkey, 14 - 17 November 2019, pp.1, (Full Text) Sustainable Development

26. Is belching increasing after bariatric by-pass surgery in the long term period?

AKYÜZ F., GÖKSOY B., TELLİ P., NİZAM N., ATASOY A., ÇAVUŞ B., et al.

United European Gastroenterology (UEG) Week 2019, Spain, 19 - 23 October 2019, vol.7, pp.703, (Summary Text)

27. EUS GUIDED ANGIOTHERAPHY IS HIGHLY EFFECTIVE TO TREATMENT OF GASTRIC VARICES : A SYSTEMATIC REVIEW AND META-ANALYSIS

Koroglu E., Shrivastava A., Akyuz F., Akyuz U., Kovuri P., Patil P., et al.

Digestive Disease Week (DDW), California, United States Of America, 18 - 21 May 2019, vol.89, (Summary Text)

28. EUS GUIDED GASTROJEJUNOSTOMY (GEJ) - IS IT READY FOR PRIME TIME?: A SYSTEMATIC REVIEW AND META-ANALYSIS

Shrivastava A., Koroglu E., Patil P., AKYÜZ F., Akyuz U., Ramireddy S., et al.

Digestive Disease Week (DDW), California, United States Of America, 18 - 21 May 2019, vol.89, (Summary Text)

29. UNDERWATER EMR IS SAFE AND HIGHLY EFFECTIVE TREATMENT FOR FLAT COLORECTAL POLYPS WITH OVERALL LOW RECURRENCE RATE : A SYSTEMATIC REVIEW AND META-ANALYSIS

Shrivastava A., Koroglu E., Kovuri P., Akyuz F., Akyuz U., Patil P., et al.

Digestive Disease Week (DDW), California, United States Of America, 18 - 21 May 2019, vol.89, (Summary Text)

30. Türkiye Yaşlılarda Uygunsuz İlaç Kullanım Kriterleri - TIME Kriterleri

BAHAT-ÖZTÜRK G., İLHAN B., ERDOĞAN T., AKYÜZ F., BİLGE A. K., ÇAKIR S., et al.

2. Uluslararası ve 12. Akademik Geriatri Kongresi, Antalya, Turkey, 24 - 28 April 2019, (Summary Text)

31. Turkısh Inappropriate Medication Use in the Elderly (TIME) Criteria

Bahat-Öztürk G., İlhan B., Erdoğan T., Halil M. G., Savaş E. S., Akyüz F., et al.

2. Uluslararası ve 12. Akademik Geriatri Kongresi, Antalya, Turkey, 24 - 28 April 2019, (Summary Text)

32. Hepatosellüler Karsinomda Ga-PSMA PET/BT’nin Rolü

HAS ŞİMŞEK D., KUYUMCU S., İLİAZ R., ŞANLI Y., BÜYÜKKAYA F., AKYÜZ F., et al.

31. ULUSAL NÜKLEER TIP KONGRESİ, Antalya, Turkey, 10 - 14 April 2019, vol.1, pp.21, (Summary Text)

33. Bone health in liver transplant recipients: Corticosteroids preserve their significance, what about late follow-up?

MİRİOĞLU Ş., ÇAKMAK DEMİR S., ILIAZ R., ÇELEN ÖĞÜNÇ H., AKYÜZ F., DEMİR K., et al.

AASLD-TASL Connect Regional Meeting, İstanbul, Turkey, 15 - 16 March 2019, vol.30, pp.21-22, (Summary Text)

34. Bone health in liver transplant recipients: Corticosteroids preserve their significance, what about late follow-up?

MİRİOĞLU Ş., ÇAKMAK DEMİR S., ILIAZ R., ÇELEN ÖGÜNÇ H., AKYÜZ F., DEMİR K., et al.

AASLD-TASL Connect Regional Meeting, İstanbul, Turkey, 15 - 16 March 2019, vol.30, pp.21-22, (Full Text)

35. Kronik Karaciğer Hastalığı Ve Kronik Hepatit C Enfeksiyonlu Hastalarda Okült Hepatit B Virüs Enfeksiyon Prevelansı

ÇAKAL B., ATASOY A., PODA M., BULAKÇI M., GÜLLÜOĞLU M., AKYÜZ F.

35. Ulusal Gastroenteroloji Kongresi, Antalya, Turkey, 25 November 2018, (Summary Text)

36. Is It Sufficient Only to Request an Anti-HCV Test for the Performance of HCV Screening?

Deniz R., Karsli S., Ekinci O. B., Kalantarova I., Atasoy A., Onel M., et al.

Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Costa Rica, 9 - 13 November 2018, vol.68, (Summary Text)

37. Clinical Impact of Endosonography in the Differantial Diagnosis of Indeterminate Biliary Strictures

Akyuz F., Deniz R., Karsli S., Akyuz U., Atasoy A., Demir K., et al.

Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Costa Rica, 9 - 13 November 2018, vol.68, (Summary Text)

38. Is there any predictor for relapse after treatment withdrawal in autoimmune hepatitis patients in the real life?

Akyuz F., Iliaz R., Cavus B., Atasoy A., Akyuz U., Demir K., et al.

68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Washington, Kiribati, 20 - 24 October 2017, vol.66, (Summary Text) Sustainable Development

39. Tens asitli siroz hastalarında intraabdominal hipertansiyonun prognoz üzerine etkisi

MUTLU Ü., ATASOY A., ILIAZ R., ÇAVUŞ B., AKYÜZ F., DEMİR K., et al.

11. Ulusal Hepatoloji Kongresi, Antalya, Turkey, 17 - 21 May 2017, pp.31-32, (Summary Text)

40. Vitamin D receptor gene polymorphisms may affect the interferon response in chronic hepatitis B patients

AKYÜZ F., UÇAR A. R., ÇİFTÇİ S., KESKİN F., ILIAZ R., ÇAVUŞ B., et al.

26th Annual Conference of APASL, Shanghai, China, 15 - 19 February 2017, vol.11, no.1, (Full Text) Sustainable Development

41. Vitamin D receptor gene polymophhism may affect the interferon response in chronic hepatitis B patients

AKYÜZ F., Uçar A. R., ÇİFTÇİ S., KESKİN F., İliaz R., Çavuş B., et al.

The 26th Conference of Asian Pacific Association for the Study of the Liver APASL Annual Meeting 2017, Şangay, China, 15 - 19 February 2017, pp.1, (Full Text) Sustainable Development

42. Kronik hepatit C’li hastalar artık daha yaşlı ve daha ciddi karaciğer hastalığı ile kliniğe başvuruyor

ILIAZ R., YÜCE İNEL T., TORUN E. S., ÇAVUŞ B., GÜLLÜOĞLU M., Bozacı M., et al.

XIII. Ulusal Viral Hepatit Kongresi, Antalya, Turkey, 17 - 20 March 2016, pp.18, (Full Text) Sustainable Development

43. Sistem temelli entegre tıp eğitiminde canlı videokonferans yöntemiyle anatomi eğitiminin dikey entegrasyonu: Canlı Anatomi.

GÜRSES İ. A., ŞANLI M. Ö., AKYÜZ F., KALE A., BARBAROS N. U., KARACA Ç., et al.

Prof. Dr. İbrahim Veli Odar Anatomi Kış Toplantısı, Kastamonu, Turkey, 11 - 14 February 2016, pp.29, (Summary Text)

44. COMPARISON OF PROGNOSTIC SCORING SYSTEMS FOR PREDICTION OF SURVIVAL IN HEPATOCELLULAR CARCINOMA

Baran B., Ekinci O., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., et al.

EASL International Liver Congress, Barcelona, Spain, 13 - 17 April 2016, (Summary Text) Sustainable Development

45. Olgu sunumu: İmmünokompetan hastada dissemine tüberküloz lenfadenopatisi

DİRİM A. B., MİRİOĞLU Ş., ÇAVUŞ B., ILIAZ R., YILMAZBAYHAN E. D., AKYÜZ F., et al.

32. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 25 - 29 November 2015, pp.94, (Full Text) Sustainable Development

46. Olgu sunumu: İmmünokompetan hastada dissemine tüberküloz lenfadenopatisi

DİRİM A. B., MİRİOĞLU Ş., ÇAVUŞ B., ILIAZ R., YILMAZBAYHAN E. D., AKYÜZ F., et al.

32. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 25 - 29 November 2015, vol.26, pp.94, (Summary Text)

47. Nedeni bilinmeyen aşikar gastrointestinal (GİS) kanamalarda kapsül deneyimimiz

Üçüncü Z. M., Bademler S., İlhan M., Gök A. F. K., Akyüz F., Güloğlu R.

10. Ulusal Travma ve Acil Cerrahi Kongresi, Antalya, Turkey, 28 October - 01 November 2015, pp.25, (Summary Text)

48. The role of cytokines and adhesion molecules in hepatocellular carcinoma to predict survival

Akyuz F., Iliaz R., AKYUZ U., Duranyildiz D., Serilmez M., Karaca C., et al.

66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Costa Rica, 13 - 17 November 2015, vol.62, (Summary Text)

49. Belching in irritable bowel syndrome: an impedance study

Akyuz F., Obekli T., Iliaz R., Arici S., Gokturk S., Karaca C., et al.

NeuroGASTRO Conference, İstanbul, Turkey, 4 - 06 June 2015, pp.38-39, (Summary Text)

50. The frequency of gastro-esophageal reflux disease in patients with mild-moderate stage chronic obstructive lung disease (COPD) and its relationship with acute exacerbations of COPD

Iliaz S., Akyuz F., Onur S. T., Akyuz U., Karaca C., Demir K., et al.

NeuroGASTRO Conference, İstanbul, Turkey, 4 - 06 June 2015, pp.70, (Summary Text)

51. Analysis of Hepatitis C Virus NS5A Region in Cirrhotic Patients Using an Ultra Deep Pyrosequencing Method

KESKİN F., ÇİFTÇİ S., AKYÜZ F., ÇAKIRİS A., ABACI N., AKYÜZ Ü., et al.

Istanbul University, World Conference on Technology, Innavation and Entrepreneurship, İstanbul, Turkey, 28 - 30 May 2015, pp.1, (Full Text) Sustainable Development

52. Cyclosporine Therapy As a Rescue Treatment in Acute Severe Ulcerative Colitis: A Real Life-Data From a Tertiary Center

Evirgen S., Iliaz R., AKYÜZ F., ÇAVUŞ B., Pinarbasi B. S., Karaca C., et al.

46th Annual Digestive Disease Week (DDW), Washington, Kiribati, 16 - 19 May 2015, vol.148, (Summary Text)

53. Chronic Renal Failure after Liver Transplantation in Long Term: Prevalence and Risk Factors.

Gokturk S., Baran B., Ormeci A., Soyer O., Evirgen S., Ozden I., et al.

Joint International Congress of ILTS, ELITA and LICAGE, London, Canada, 4 - 07 June 2014, vol.20, (Summary Text)

54. SMALL BOWEL MUCOSAL FINDINGS IN FAMILIAL MEDITERRANEAN FEVER

Demir A., Akyuz F., Gokturk S., Evirgen S., Gulluoglu M., Erer B., et al.

15th Annual European Congress of Rheumatology (EULAR), Paris, France, 11 - 14 June 2014, pp.307, (Summary Text)

55. ENTECAVIR AND TENOFOVIR HAVE A COMPARABLE EFFICACY IN TREATMENT OF NUCLEOS(T)IDE ANALOGUE NAIVE PATIENTS WITH CHRONIC HEPATITIS B: A REAL LIFE EXPERIENCE

Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.

49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver, London, Canada, 9 - 13 April 2014, (Summary Text)

56. Baseline alfa-fetoprotein level is a strong predictor of vascular invasion and survival in patients with hepatocellular carcinoma

Ekinci O., Baran B., Ormeci A., Soyer O. M., Gokturk S., Poyanli A., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 November 2013, vol.58, (Summary Text)

57. Tenofovir disoproxil fumarate has a substantial efficacy against adefovir and multi-drug resistant strains of hepatitis B virus

Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 November 2013, (Summary Text) Sustainable Development

58. Virological Supression Does not Prevent the Development of Hepatocellular Carsinoma in Cirrhotic Patients with Genotype D Hepatitis B Infection

Gokturk S., Basar R., Ucar A. R., Basgoze B. H., Altinkaynak M., Buyukballi P., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 November 2013, vol.58, (Summary Text) Sustainable Development

59. Risk factors for significant liver fibrosis in genotype D HBeAg-negative chronic hepatitis B infection with persistently normal ALT and high serum HBVDNA levels

Ormeci A., Akyuz F., Baran B., Soyer O. M., Gokturk S., Karaca C., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 November 2013, (Summary Text) Sustainable Development

60. The antiviral efficacy of entecavir is not influenced by prior treatment with nucleos(t)ide analogues in patients with chronic hepatitis B

Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 November 2013, (Summary Text)

61. Safety of Tenofovir in Renal Transplanted and Hemodialysis Patients with Chronic Hepatitis B

Akyuz F., Gokturk S., Baran B., Ormeci A., Soyer O. M., Evirgen S., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 November 2013, vol.58, (Summary Text) Sustainable Development

62. IL28B Polymorphisms and Influence on Sustained Virological Response to Interferon Therapy in Chronic DELTA Hepatitis.

Karaca C., Yılmaz E., Mutluay Soyer O., Onel D., Onel M., Baran B., et al.

Digestive Disease Week / 28th Annual Residents and Fellows Research Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT), Orlando, United States Of America, 18 - 21 May 2013, vol.144, no.5, (Full Text) Sustainable Development

63. Acil üst gis endoskopi ile farkedilen ampüller nöroendokrin karsinom

İşcan A. Y., Karip A. B., Özbay N., Taşdelen İ., Akyüz F., Memişoğlu K.

11. Ulusal Endoskopik Laparoskopik Cerrahi Kongresi, Muğla, Turkey, 2 - 06 October 2013, vol.20, no.1, pp.144, (Full Text)

64. IL28B Polymorphisms and Influence on Sustained Virological Response to Interferon Therapy in Chronic DELTA Hepatitis

Karaca C., Yilmaz E., Soyer O. M., Onel D., ÖNEL M., Baran B., et al.

Digestive Disease Week / 28th Annual Residents and Fellows Research Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT), Florida, United States Of America, 18 - 21 May 2013, vol.144, (Summary Text) Sustainable Development

65. Does Chemoprophylaxis Prevent Tuberculosis Reactivation in the Long Term Period of Anti-TNF Treatment?

AKYÜZ F., Soyer O. M., Gokturk S., ÇİFCİBAŞI ÖRMECİ A., Evirgen S., Onder S. Y., et al.

66. Zor gastrointestinal kanamalarda kapsül endoskopinin yeri

İlhan M., Üçüncü M. Z., Gök A. F. K., Yanar H. T., Güloğlu R., Akyüz F., et al.

9. Ulusal Travma ve Acil Cerrahi Kongresi, Antalya, Turkey, 19 - 23 April 2013, pp.36, (Summary Text)

67. TREATMENT FAILURE MAY LEAD TO ACCELERATED FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C

Baran B., Gulluoglu M., Soyer O., Ormeci A., Gokturk S., Evirgen S., et al.

International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Amsterdam, Netherlands, 24 - 28 April 2013, (Summary Text)

68. Response to tenofovir treatment of treatment-naive and adefovir experienced patients with chronic hepatitis b

KESKİN O., Ormeci A., Kabacam G., Akyuz F., Aniktar H., Karaca C., et al.

63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America, 9 - 13 November 2012, vol.56, (Summary Text) Sustainable Development

69. Number connection test-A and inhibitor control test are not efficient for diagnosis of minimal hepatic encephalopathy in cirrhotic patients

Baran B., Ozcan E., Oztop N., Cakmak R., Soyer O. M., Ormeci A., et al.

63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America, 9 - 13 November 2012, vol.56, (Summary Text)

70. EVALUATION OF MICA, HLA-DRB1 AND HLA-DQB1 GENOTYPES IN PATIENTS WITH ULCERATIVE COLITIS

Kekik C., Pinarbasi B., Akyuz F., Oguz F., Demir K., Carin M. N.

Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference, Liverpool, United Kingdom, 31 May - 03 June 2012, vol.79, pp.577, (Summary Text)

71. Hepatosellüler karsinom hastalarında Yttrium 90 mikroküre ile yapılan selektif internal radyonüklid tedavi

ÖZKAN Z. G., UÇAR A., KUYUMCU S., AKYÜZ F., POYANLI A., KESKİN S., et al.

25. Ulusal Nükleer Tıp kongresi, Turkey, 6 - 10 April 2013, pp.8

72. Success of Two Different Endoscopic Submucosal Resection Methods in Gastric Subepithelial Lesions

Karaca C., Soyer O. M., Akyuz F., Baran B., Ormeci A., Gokturk S., et al.

Digestive Disease Week (DDW), California, United States Of America, 19 - 22 May 2012, vol.75, pp.136, (Summary Text)

73. RESPONSE TO TENOFOVIR TREATMENT OF TREATMENT-NAIVE VS ADEFOVIR-RESISTANT VS SUBOPTIMAL RESPONDER PATIENTS WITH CHRONIC HEPATITIS B

Keskin O., Ormeci A., Kabacam G., Akyuz F., Aniktar H., Karaca C., et al.

47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Barcelona, Spain, 18 - 22 April 2012

74. Ülseratif kolitli hastalarda MICA, HLA-DRB1 ve HLA-DQB1 genotiplerinin değerlendirilmesi

KEKİK ÇINAR Ç., PINARBAŞI B., AKYÜZ F., OĞUZ F., DEMİR K., ÇARİN M.

12. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Antalya, Turkey, 27 - 30 October 2011, pp.6, (Full Text)

75. ANTIVIRAL RESISTANCE IN NAIVE GENOTYPE D CHRONIC HEPATITIS B PATIENTS BY ULTRA-DEEP PYROSEQUENCING

Akyuz F., Ciftci S., Keskin F., Pinarbasi B., Baran B., Ustek D., et al.

62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Costa Rica, 4 - 08 November 2011, vol.54, (Summary Text) Sustainable Development

76. ENDOSONOGRAFİK OLARAK STROMAL TÜMÖRÜ TAKLİT EDEN MİDENİN METASTATİK TÜMÖRÜ

AKYÜZ Ü., AKYÜZ F., ÖZTÜRK SARI Ş., FIRAT P.

27. ULUSAL GASTROENTEROLOJİ HAFTASI, Antalya, Turkey, 24 - 28 November 2010, pp.253, (Full Text)

77. PRECORE/CORE PROMOTER MUTATIONS BY ULTRA-DEEP PYROSEQUENCING IN GENOTYPE D CHRONIC HEPATITIS B NAIVE PATIENTS

AKYÜZ F., ÇİFTÇİ S., KESKİN F., PINARBAŞI B., ÇAKİRİS A., ABACI N., et al.

45th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Viyana, Austria, 14 April 2010 - 18 April 2014, pp.238, (Full Text) Sustainable Development

78. Does Cholecystectomy Increase the Esophageal Alkaline Reflux? Evaluation by Impedance-pH Technique

Uyanikoglu A., AKYÜZ F., Bas G., Cakirca M., Baran B., Ermis F., et al.

Digestive Disease Week/111th Annual Meeting of the American-Gastroenterological-Association, Louisiana, United States Of America, 1 - 06 May 2010, vol.71, (Summary Text)

79. PRECORE/CORE PROMOTER MUTATIONS BY ULTRA-DEEP PYROSEQUENCING IN GENOTYPE D CHRONIC HEPATITIS B NAIVE PATIENTS

Akyuz F., Ciftci S., Keskin F., Pinarbasi B., Cakiris A., Abaci N., et al.

45th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Vienna, Austria, 14 - 18 April 2010, (Summary Text)

80. Ultra-Deep Pyrosekans (UDPS) yöntemi ile naiv kronik B hepatitli hastalarda antiviral direnç araştırılması

AKYÜZ F., ÇİFTÇİ S., KESKİN F., Pınarbaşı B., Baran B., ÇAKIRİS A., et al.

26. Ulusal Gastroenteroloji Haftası, Ankara, Turkey, 14 - 18 October 2009, pp.206, (Full Text)

81. Ultra-Deep Pyrosekans (UDPS) yöntemi ile naiv B tipi kronik hepatit olgularında hepatit B virüsü (HBV) tüm genom analizi

ÇİFTÇİ S., KESKİN F., ÇAKIRİS A., AKYÜZ F., Pınarbaşı B., ABACI N., et al.

26. Ulusal Gastroenteroloji Haftası, Ankara, Turkey, 14 - 18 October 2009, pp.207, (Full Text) Sustainable Development

82. Ultra-Deep Sekans yöntemi ile naiv kronik B hepatitli hastalarda tüm genom analizinde precore/core-promoter mutasyon sonuçları

AKYÜZ F., ÇİFTÇİ S., Keskin F., Pınarbaşı B., Baran B., ÇAKIRİS A., et al.

26. Ulusal Gastroenteroloji Haftası, Ankara, Turkey, 14 - 18 October 2009, pp.27, (Full Text)

83. What is the cause of iron overload in HBV related chronic liver disease

Yönal O., AKYÜZ F., ÇİFTÇİ S., Keskin F., Pınarbaşı B., Uyanıkoğlu A., et al.

British Society of Gastrenterology Annual General Meeting, Glasgow, United Kingdom, 23 - 26 March 2009, pp.1955, (Full Text)

84. HBsAg CLEARENCE AFTER LONG-TERM FOLLOW-UP IN CHRONIC HEPATITIS B PATIENTS TREATED WITH INTERFERON ALPHA AND NUCLEOS(T)IDE ANALOGUES

Pinarbasi B., Kaymakoglu S., Akyuz F., Issever H., Ermis F., Uyanikoglu A., et al.

44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Copenhagen, Denmark, 22 - 26 April 2009, (Summary Text)

85. Ultra-Deep Pyrosekans (UDPS) yöntemi ile naiv kronik B hepatitli hastalarda antiviral direnç araştırılması.

AKYÜZ F., ÇİFTÇİ S., KESKİN F., PINARBASI B., ÇAKIRİS A., ABACI N., et al.

26. Ulusal Gastroenteroloji Haftası, Ankara, Turkey, 14 - 18 October 2008, pp.206, (Summary Text)

86. Influence of ghrelin on gastric accommodation and meal-induced satiety in man

Ang D. C., Nicolai H., Vos R., Vanden Berghe P., Sifrim D., Mimidis K., et al.

Digestive Disease Week Meeting/109th Annual Meeting of the American-Gastroenterological-Association, California, United States Of America, 17 - 22 May 2008, vol.134

87. The presence of HCVRNA in the peripheral blood mononuclear cells of the individuals with isolated anti HCV positivity: Is HCV hiding out?

Pinarbasi B., Bozaci M., Akyuz F., Badur S., Demir K., Besisik F., et al.

43rd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Milan, Italy, 23 - 27 April 2008, (Summary Text) Sustainable Development

88. A new agent for tumour necrosis factor-alpha inhibition: In vitro effects of dipyridamole in Crohn's disease

Poturoglu S., KAYMAKOĞLU S., polat N. G., Ibrisim D., Ahishali E., AKYÜZ F., et al.

Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington, Kiribati, 19 - 24 May 2007, vol.132, (Summary Text)

89. Role of mucosal nerve endings in acid-induced duodenogastric sensorimotor reflexes in man

Vanuytsel T., Mimidis K., AKYÜZ F., Vos R., Tack J.

Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington, Kiribati, 19 - 24 May 2007, vol.132, (Summary Text)

90. Influence of NK-1 receptor antagonist-aprepitant on rectal sensitivity and compliance in healty volunteers

AKYÜZ F., Mimidis K., Nikolai H., Vos R., Tack J.

Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington, Kiribati, 19 - 24 May 2007, vol.132, (Summary Text)

91. Influence of itopride and domperidone on gastric tone and on the perception of gastric distention in healthy subjects

AKYÜZ F., Mimidis K., Nikolai H., Vos R., Tack J.

Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington, Kiribati, 19 - 24 May 2007, vol.132, (Summary Text)

92. Influence of duodenal acidification on meal-related symptoms and satiety induced by the slow nutrient drink test in man

Mimidis K., AKYÜZ F., Nicolai H., Vos R., Vanuytsel T., Tack J.

Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington, Kiribati, 19 - 24 May 2007, vol.132

93. Influence of naloxone on meal-related symptoms and gastric emptying rate in man

Mimidis K., AKYÜZ F., Geeraens B., Nicolai H., Vos R., Tack J. F.

Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington, Kiribati, 19 - 24 May 2007, vol.132

94. Intestinal metaplasia in portal hypertensive gastropathy: Is it a part of natural course

Ibrisim D., Cevikbas U., Akyuz F., Poturoglu S., Ahishali E., Gulluoglu M., et al.

Digestive Disease Week Meeting/107th Annual Meeting of the American-Gastroenterlogical-Association, Los-Angeles, Chile, 20 - 25 May 2006, vol.130, (Summary Text)